| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Pamidronate | FAERS: 4 | US FAERS | |
| 2 | Sorafenib | FAERS: 4 | US FAERS | |
| 3 | Rivastigmine | FAERS: 3 | US FAERS | |
| 4 | Aripiprazole | FAERS: 2 | US FAERS | |
| 5 | Fingolimod Hydrochloride | FAERS: 2 | US FAERS | |
| 6 | NuvaRing | FAERS: 2 | US FAERS | |
| 7 | Venlafaxine Hydrochloride | FAERS: 2 | US FAERS | |
| 8 | 4-Aminopyridine | FAERS: 1 | US FAERS | |
| 9 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 10 | Axitinib | FAERS: 1 | US FAERS | |
| 11 | Lisinopril | FAERS: 1 | US FAERS | |
| 12 | Methylphenidate | FAERS: 1 | US FAERS | |
| 13 | Rabeprazole | FAERS: 1 | US FAERS | |
| 14 | Risperidone | FAERS: 1 | US FAERS | |
| 15 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 16 | Teriparatide | FAERS: 1 | US FAERS | |
| 17 | Varenicline | FAERS: 1 | US FAERS | |
| 18 | pazopanib | FAERS: 1 | US FAERS | |
| 19 | sofosbuvir-velpatasvir drug combination | FAERS: 1 | US FAERS | |
| 20 | tofacitinib | FAERS: 1 | US FAERS | |
| 21 | Dexmedetomidine | SIDER | ||
| 22 | Duloxetine Hydrochloride | SIDER | ||
| 23 | Etoricoxib | SIDER | ||
| 24 | Meperidine | Canada Vigilance: 1 | Canada Vigilance | |
| 25 | Venlafaxine Hydrochloride | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120267
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.